Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT06937697Phase 3Completed
Phase 3, randomised trial in dentin hypersensitivity (DH) (2 arms), sponsored by Colgate-Palmolive. Primary endpoints: tactile sensitivity at 8 weeks and air blast sensitivity at 8 weeks. Started Oct 2024; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT06937697.